Skip to content

Drug interactions

Efavirenz + Indacaterol-glycopyrronium

Severity: Moderate

Efavirenz and Indacaterol-glycopyrronium: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Efavirenz can prolong the QT interval, particularly at higher exposures, and indacaterol may contribute modestly to repolarization changes. The combination may add to arrhythmia risk, especially with hypokalemia or other risk factors.

What this interaction means in plain words

Efavirenz and Indacaterol-glycopyrronium can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Efavirenz belongs to Anti Virals; Indacaterol-glycopyrronium belongs to Respiratory.

Evidence level: Low

Why it happens

Additive effects on cardiac repolarization.

What to do

Consider baseline ECG in patients with QT risk factors and correct electrolyte disturbances. Monitor for palpitations or syncope.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Efavirenz and Indacaterol-glycopyrronium, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Efavirenz with Indacaterol-glycopyrronium?

MediHelp rates the interaction as moderate. Efavirenz and Indacaterol-glycopyrronium can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Efavirenz can prolong the QT interval, particularly at higher exposures, and indacaterol may contribute modestly to repolarization changes. The combination may add to arrhythmia risk, especially with hypokalemia or other risk factors.

How serious is the interaction between Efavirenz and Indacaterol-glycopyrronium?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Consider baseline ECG in patients with QT risk factors and correct electrolyte disturbances. Monitor for palpitations or syncope.

What other medicines interact with Indacaterol-glycopyrronium?

MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in